Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Baseline soluble MICA levels act as a predictive biomarker for the efficacy of regorafenib treatment in colorectal cancer

Fig. 4

ROC analysis of sMICA and the comparison of PFS and OS according to sMICA level. A ROC analysis of sMICA levels for the detection of responders was conducted. B PFS and OS between low and high plasma sMICA level groups were analyzed. C Kaplan–Meier analyses of PFS and OS according to the sMICA levels were conducted. PFS: progression-free survival, OS: overall survival

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us